Farmers & Merchants Investments Inc. decreased its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 78,963 shares of the pharmacy operator’s stock after selling 6,000 shares during the period. Farmers & Merchants Investments Inc.’s holdings in Walgreens Boots Alliance were worth $5,734,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also bought and sold shares of the company. Hudock Capital Group LLC lifted its position in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares in the last quarter. Westside Investment Management Inc. lifted its position in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares in the last quarter. Zions Bancorporation lifted its position in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares in the last quarter. IHT Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 2,199 shares in the last quarter. Finally, Bristlecone Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance in the third quarter worth approximately $135,000. Institutional investors own 61.57% of the company’s stock.
Shares of Walgreens Boots Alliance Inc (WBA) opened at $68.46 on Tuesday. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. The firm has a market cap of $67,820.00, a price-to-earnings ratio of 18.91, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.10 earnings per share. equities analysts forecast that Walgreens Boots Alliance Inc will post 5.71 EPS for the current fiscal year.
Walgreens Boots Alliance declared that its board has initiated a share buyback plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be issued a dividend of $0.40 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.34%. Walgreens Boots Alliance’s payout ratio is presently 44.20%.
In related news, insider Stefano Pessina acquired 98,858 shares of the business’s stock in a transaction on Monday, January 15th. The stock was bought at an average cost of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 14.80% of the stock is currently owned by company insiders.
A number of research firms have recently issued reports on WBA. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $88.00 price objective (up previously from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. ValuEngine lowered shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Vetr lowered shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 1st. Finally, Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Thursday, October 26th. Eleven analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus price target of $85.53.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/13/farmers-merchants-investments-inc-has-5-73-million-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.